Intellia Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 43
EBIT TTM (mln): -538
index 0 1 2 3 4 5 6 7 8 9 10
Rok finansowy 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 6 16 26 30 43 58 33 52 36 58
Przychód Δ r/r 0.0% inf% 172.7% 58.5% 16.5% 41.6% 34.5% -43.0% 57.7% -30.4% 59.6%
Marża brutto -inf% 100.0% 100.0% 100.0% 100.0% -151.5% -159.4% 79.2% 85.5% 75.3% 100.0%
EBIT (mln) -5 -13 -32 -70 -91 -106 -137 -268 -458 -515 -534
EBIT Δ r/r 0.0% 156.6% 139.8% 116.3% 30.6% 17.1% 28.4% 96.1% 71.1% 12.5% 3.7%
EBIT (%) 0.0% -221.9% -195.2% -266.3% -298.6% -246.8% -235.5% -810.4% -879.0% -1420.5% -923.1%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 9 0 0
EBITDA (mln) -10 -13 -32 -70 -91 -101 -137 -268 -445 -506 -524
EBITDA(%) 0.0% -216.4% -195.2% -266.3% -298.6% -233.8% -235.5% -810.4% -853.2% -1395.5% -905.3%
Podatek (mln) 0 -1 -1 -3 6 -7 -9 -8 16 -50 0
Zysk Netto (mln) -14 -12 -32 -68 -85 -93 -126 -260 -490 -481 -519
Zysk netto Δ r/r 0.0% -13.4% 155.2% 113.5% 26.4% 8.6% 35.5% 106.8% 88.7% -1.8% 7.9%
Zysk netto (%) 0.0% -205.1% -192.0% -258.6% -280.4% -215.1% -216.5% -785.8% -940.5% -1326.5% -896.8%
EPS -29.45 -0.7 -1.42 -1.88 -1.98 -1.96 -2.24 -3.66 -6.37 -5.42 -5.25
EPS (rozwodnione) -29.45 -0.7 -1.42 -1.88 -1.98 -1.96 -2.24 -3.66 -6.37 -5.42 -5.25
Ilośc akcji (mln) 0 18 22 36 43 47 56 71 77 89 99
Ważona ilośc akcji (mln) 0 18 22 36 43 47 56 71 77 89 99
Waluta USD USD USD USD USD USD USD USD USD USD USD